Hawkins, Inc. Expands Pharmaceutical Ingredient Capabilities Roseville, MN, June 22, 2021 (GLOBE NEWSWIRE) -- Hawkins, Inc. (Nasdaq: HWKN), a leading specialty chemical company, today announced that it has completed a capital investment in its Minneapolis, MN facility to drive further growth in its pharmaceutical ingredient business. The total overall investment of approximately $5 million included automation capabilities and additional storage for raw materials and finished goods. The addition more than doubles the facilitys pharmaceutical capacity in a controlled environment to support the industrys estimated demands and allows for larger quantity production campaigns.